As the revision of EU chemicals legislation REACH is underway, the Health and Environment Alliance urges the European Commission to uphold its commitments on safer chemicals and ensure that ambitious health protections remain at the heart of the project.
As the EU Commission and representatives of member states gather on 3 April 2025 to discuss the reform of EU chemicals legislation REACH, HEAL stresses the importance of putting health at the core of the revision. The CARACAL meeting will see the EU Commission present their initial plan for reforming REACH.
The REACH legislation sets out how the European Union registers, evaluates, authorises and restricts chemicals. The sorely needed overhaul of this juggernaut of EU chemicals legislation is an opportunity to strengthen its effectiveness in protecting our health and the environment through better and earlier identification of hazardous chemicals.
HEAL, together with the European Environmental Bureau (EEB) and ChemTrust, has submitted joint comments to the Commission proposal on new REACH information requirements for endocrine disruptors.
The undersigned organisations urge the REACH committee to advocate for accelerating the implementation of the restriction agenda, which is crucial for the timely phase-out of the most harmful chemicals within the EU and support the progressive industry.
HEAL supports the proposed amendments to the REACH authorisation list entries for Dibutyl phthalate (DBP), which is listed as a substance of very high concern under REACH due to its toxicity for reproductive prpoerties and its endocrine disrupting effects on human health and the environment.
HEAL strongly supports the inclusion of melamine, a substance that's harmful for human health and the environment, in the authorisation list of REACH.
